We're still accepting applications for Fall 2026!
Apply Today
Today’s influenza vaccines primarily prevent infection in individuals, but new research led by the University of Michigan and the Institut Pasteur suggests that incorporating antibodies generated after infection could lead to more powerful vaccines by also reducing person-to-person transmission.
One dose of the antiviral baloxavir marboxil lowers the chance of transmitting the influenza virus to family members by about 30%, according to new research in the New England Journal of Medicine from University of Michigan researchers.
Aubree Gordon, professor of Epidemiology and Global Public Health, has been awarded a $6.7 million five-year grant to advance her innovative research into influenza immunity development among children.
US flu vaccines are likely to move from quadrivalent to trivalent due to a change in circulating influenza viruses, says University of Michigan School of Public Health researcher Arnold Monto.
The Food and Drug Administration’s expert vaccine advisory panel on Thursday unanimously endorsed the idea of taking a strain of influenza viruses that no longer appears to circulate out of flu shots as quickly as possible, pressing the FDA and manufacturers to try to get the work done on an expedited timeline.
In this New York Times opinion article, Aubree Gordon, associate professor of Epidemiology, discusses the respiratory viruses we'll likely see this winter.